Answers are grounded in this paper and cite their sources.
The spread of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae continues to increase, and the possible development of KPC-producing K. pneumoniae infections in cystic fibrosis (CF) patients is a matter of concern. Here, we describe the establishment of a chronic lung infection due to a colistin-resistant KPC-producing K. pneumoniae isolate in an Italian CF patient.
No takes yet. Share an insight, caveat, or question.
Delfino et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: